The historical rank and industry rank for Medicalgorithmics's FCF Margin % or its related term are showing as below:
LTS:0QR8'
s FCF Margin % Range Over the Past 10 Years
Min: -96.02 Med: -8.83 Max: 21.1
Current: -42.81
During the past 13 years, the highest FCF Margin % of Medicalgorithmics was 21.10%. The lowest was -96.02%. And the median was -8.83%.
LTS:0QR8's FCF Margin % is ranked worse than 77.33% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.22
vs LTS:0QR8: -42.81
Medicalgorithmics FCF Margin % Related Terms
Medicalgorithmics FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QR8 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Medicalgorithmics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicalgorithmics (LTS:0QR8) has a FCF Margin % of -25.93% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medicalgorithmics and its competitors. According to the industry distribution chart, Medicalgorithmics ranks #631 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 77.3%.
Is Medicalgorithmics' FCF Margin % too high?
Medicalgorithmics' current FCF Margin % is -25.93%. Based on the distribution chart, Medicalgorithmics ranks #631 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medicalgorithmics has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #631 out of 816 companies for FCF Margin %. This places Medicalgorithmics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current FCF Margin % is -25.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (LTS:0QR8) has a current FCF Margin % of -25.93%. The stock's GF Value™ is zł31.62, compared to a current price of zł33.07 — trading 4.6% above its estimated fair value. The current FCF Margin % is -25.93%. Medicalgorithmics' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medicalgorithmics (LTS:0QR8), the current FCF Margin % is -25.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (LTS:0QR8) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued.
The current stock price of zł33.07 is trading 4.6% above its estimated GF Value™ of zł31.62.
Key valuation signals for LTS:0QR8:
FCF Margin %: -25.93%
GF Value™: zł31.62 vs. price of zł33.07 (4.6% above fair value)
No single metric tells the full story. See the LTS:0QR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
71GF Score
Get the complete analysis for LTS:0QR8
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QR8 has been successfully added to your 
